• Chronoscale committed on May 29, 2026 to divest wholly owned subsidiary Ekso Bionics, shifting to a cloud-only operating focus.
• Divestiture is targeted for completion in the first fiscal quarter.
• Exit-related charges are expected to be material, including severance, lease termination payments, transaction costs, and other exit expenses.
• No estimate was provided for the total charges tied to the divestiture.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chronoscale Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-027271), on June 04, 2026, and is solely responsible for the information contained therein.